Traduction de «addiction to tobacco » (Anglais → Français) :

smoking [ addiction to tobacco | anti-smoking campaign | nicotinism | tobacco addiction ]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

tobacco addiction | tobacco dependence | tobacco dependency

drug addiction [ drug abuse | drug-taking | fight against drugs | drug addicts(UNBIS) ]

Tobacco, Nicotine and Addiction: a Committee Report

tobacco [ Tobacco product(STW) ]

homogenized leaf [ reconstituted binder leaf | homogenized tobacco | homogenized tobacco leaf | sheet tobacco | reconstituted tobacco ]

Maternal care for (suspected) damage to fetus from drug addiction

Fetus and newborn affected by maternal use of drugs of addiction

...dren, and to fight their addiction to tobacco and dependence on its use; (d) to develop a multi-year strategy to combat the use of tobacco products by young persons and to involve young persons as much as possible in the design and execution of any programs that are part of the strategy; (e) to examine existing models of best practices for tobacco control in North America and, in consultation with recognized health organizations, to develop a model to be applied in Canada and to review it from time to time by comparing it with other models developed in other countries; (f) to monitor the use of tobacco products throughout Canada by ...[+++] gathering, commissioning, sharing and publicizing statistics and, in particular, statistics on the market share of brands and on their use by different groups of young persons; (g) to gather, sponsor, commission, conduct and share research on the use of tobacco products throughout Canada and on ways to motivate young persons not to start using tobacco products and to cease using them; (h) to develop and distribute educational tools, plan and execute communications strategies, run advertising campaigns, use the media and disseminate information through other means to discourage and prevent the use of tobacco products by young persons; (i) to hold and sponsor programs, conferences and peer and other group activities to discourage and prevent the use of tobacco products by young persons; (j) to engage in and fund, at the local, regional and national levels throughout Canada, activities of health groups and other organizations and persons that are intended to discourage and prevent the use of tobacco products by young persons; (k) to organize, promote, coordinate, participate in and support, throughout Canada and elsewhere, financially and otherwise, all forms of activity that assists in the protection of young persons from the use of tobacco products; (l) to recommend initiatives by government, the tobacco industry and others that could help to prevent use of tobacco products by young persons; (m) to receive, hold and spend the funds raised by the levy imposed by this Act in order to attain its objects; (n) to receive, hold and spend gifts, legacies and grants in order to attain its objects; and (o) generally, to do all such things as are conducive to the attainment of its objects. ...

To gather more information on the ingredients contained in tobacco products and their effects on health and addiction, manufacturers and importers of tobacco products are required to report on ingredients in all products they place on the EU market through a standardised electronic format.

Tobacco products for oral use and smokeless tobacco products: there are separate provisions for these two categories of products, i.e. the following warning: This tobacco product can damage your health and is addictive.

consider measures to reduce the attractiveness and addictiveness of tobacco products (as reflected in the revision of the Tobacco Products Directive adopted in 2014 — Directive 2014/40/EU).